Systematic (IUPAC) name
naphthalen-1-yl 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylate
Clinical data
Legal status
Chemical data
Formula C26H18FNO2
Molecular mass 395.42 g/mol

FDU-PB-22 is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2]

Legal status

FDU-PB-22 is a controlled substance in Germany and is also banned in Japan and Sweden.[3]

See also


  1. ^ "FDU-PB-22". Southern Association of Forensic Scientists. Retrieved 23 July 2015. 
  2. ^ Nahoko Uchiyama, Yoshihiko Shimokawa, Ruri Kikura-Hanajiri, Yosuke Demizu, Yukihiro Goda, Takashi Hakamatsuka (February 2015). "A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products". Forensic Toxicology.  
  3. ^ "Cannabinoider föreslås bli klassificerade som hälsofarlig vara". Folkhälsomyndigheten. 28 May 2014. Retrieved 23 July 2015.